|
Report ID
|
19888 |
|
Drug Identification Number
|
02312557 |
|
Brand name
|
BOOSTRIX-POLIO |
|
Common or Proper name
|
Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine |
|
Company Name
|
GLAXOSMITHKLINE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
INACTIVATED POLIOVIRUS TYPE I
INACTIVATED POLIOVIRUS TYPE II
INACTIVATED POLIOVIRUS TYPE III
TETANUS TOXOID ADSORBED
DIPHTHERIA TOXOID ADSORBED
PERTUSSIS TOXOID ADSORBED
FILAMENTOUS HAEMAGGLUTININ ADSORBED
PERTACTIN ADSORBED |
|
Strength(s)
|
40D
8D
32D
5.0LF
2.5LF
8MCG
8MCG
2.5MCG |
|
Dosage form(s)
|
SUSPENSION |
|
Route of administration
|
INTRAMUSCULAR |
|
Packaging size
|
10's |
|
ATC code
|
J07CA |
|
ATC description
|
BACTERIAL AND VIRAL VACCINES, COMBINED |
|
Reason for shortage
|
Delay in shipping of the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2017-11-08 |
|
Estimated end date
|
2017-12-07 |
|
Actual end date
|
2017-12-06 |
|
Shortage status
|
Resolved |
|
Updated date
|
2017-12-07 |
|
Company comments
|
Supply released November 10, 2017 with limited quantity. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
1-800-387-7374 |
